Tyler Panzner
Tyler Panzner is a researcher who focuses on cell signaling models of disease and symptom triggers. His peer-reviewed research examines cellular mechanisms in breast cancer progression, including cell migration, invasion, and metastatic seeding. Additionally, his publications explore the properties and behavior of extracellular vesicles and exosomes in the context of HIV infection.
30 claims checked on air: 3 contradicted 6 overstated 20 supported 1 unverified
What they said on air - overstated
Sleep-deprivation-induced hallucinations occur because the brain becomes hypersensitive to endogenous serotonin and DMT.
"when people start to hallucinate from sleep deprivation, you know, it's because they're literally getting hypersensitive to their brain's own serotonin and DMT." (said at 0:12:05)
Preclinical research in mice demonstrates that acute sleep deprivation can rapidly upregulate 5-HT2A serotonin receptors in the frontal cortex via the immediate early gene Egr3 (PMID: 35001075). However, attributing human sleep-deprivation hallucinations to the brain becoming hypersensitive to endogenous serotonin and DMT is an overstatement. There is no empirical evidence establishing that endogenous DMT plays a causative role in sleep-deprivation hallucinations or that receptor hypersensitivity to endogenous DMT drives psychotic symptoms in humans.
In a 3-year clinical trial where humans took 10,000 IU of vitamin D daily without vitamin K2, participants developed no arterial calcification, and those with pre-existing calcification experienced no progression.
"We have clinical studies. They gave humans 10,000 IUs a day with no vitamin K2, which apparently should make you calcified. But they gave them 10,000 IUs every single day for 3 years. They measured their blood vessels, their arteries for calcification before and after 3 years. Not only did no one form any calcification, but the people that had existing calcification before the vitamin D had no more calcification." (said at 0:21:47)
The speaker refers to a 3-year randomized controlled trial (a secondary analysis of the Calgary Vitamin D Study) that evaluated 302 healthy adults randomized to 400, 4,000, or 10,000 IU of daily vitamin D3 without vitamin K2. The trial's findings partially support the claim but contradict the speaker's second assertion:
1. New calcification: Supported. High-resolution peripheral quantitative computed tomography (HR-pQCT) of the tibial artery showed that no participants without baseline calcification developed new arterial calcification over 3 years in any treatment arm.
2. Pre-existing calcification: Overstated/contradicted. Among the 85 participants with baseline tibial artery calcification, calcification quantity did not disappear or halt; it increased linearly over time at 0.020 mgHA/month (95% CI: 0.012 to 0.029). The 10,000 IU daily dose neither accelerated nor halted/reversed this progression compared to lower doses (p = 0.645 for group interaction).
Curcumin lowers dihydrotestosterone (DHT).
"what if it said boost neurotransmitters, can raise adrenaline, iron chelator, copper chelator, lowers DHT?" (said at 0:32:48)
Preclinical in vitro assays and cell culture models indicate that curcumin can inhibit 5α-reductase (the enzyme that converts testosterone to dihydrotestosterone) and decrease dihydrotestosterone (DHT) levels in cell models. However, there is a lack of robust human clinical trial evidence demonstrating that dietary or supplemental curcumin meaningfully lowers circulating DHT levels in humans.
In a human study where participants were injected with liquid histamine, increasing histamine within the upper-normal range caused increased heart rate and anxiety as the first symptoms.
"They did a study: they injected humans with pure liquid histamine... What was the first symptom that showed up? If here's the range of normal histamine levels, even going from middle of normal to upper normal, that is still in the normal range, first thing that happened was increased heart rate and anxiety." (said at 0:41:20)
Human intravenous histamine infusion studies show that an increase in heart rate (tachycardia) is indeed the first objective physiological response to appear as plasma histamine rises, occurring at a lower concentration threshold than flushing, headache, or blood pressure changes. However, the claim overstates the details: achieving a 30% increase in heart rate required elevating plasma histamine above resting baseline levels (to ~1.61 ng/mL compared to a baseline of ~0.62 ng/mL), rather than remaining within the middle-to-upper normal range. Additionally, anxiety was not documented as a primary symptom or endpoint in these infusion protocols.
Supplementation with Rhodiola rosea can raise adrenaline levels.
"Whether you're taking a quercetin supplement that raises adrenaline, or a Rhodiola rosea that can do that, or you're having tomatoes or vinaigrette for lunch, or you're having garlic, onions, or tomatoes for dinner." (said at 0:48:53)
Evidence that Rhodiola rosea supplementation increases circulating adrenaline (epinephrine) levels is lacking. In a randomized crossover trial evaluating short-term Rhodiola rosea supplementation (1500 mg/day) during resistance exercise, resting norepinephrine levels were higher compared to placebo, but epinephrine levels were not significantly different between conditions. Furthermore, preclinical studies generally describe Rhodiola rosea as an adaptogen with anti-adrenergic and cardioprotective actions that blunt excessive stress-induced catecholamine surges rather than stimulating adrenaline release.
One-third of people are hyper-responders to saturated fat, causing their LDL levels to spike significantly and potentially leading to weight gain.
"Red meat is highly nutritious, but one-third of people are hyper-responders to saturated fat, so their LDL goes through the roof. It could be linked to more weight gain." (said at 1:09:20)
The speaker conflates several concepts regarding dietary lipid responses. In nutritional science, the concept of 'hyper-responders' most commonly refers to dietary cholesterol challenges (such as egg feeding studies), where approximately 25% of individuals experience more pronounced increases in plasma cholesterol (both LDL-C and HDL-C), while roughly 75% show little to no response. When evaluated in randomized dietary trials altering saturated versus polyunsaturated fat intake, cholesterol response follows a continuous, graded distribution rather than defining a discrete one-third subpopulation of 'hyper-responders.' Furthermore, there is no robust evidence establishing that saturated-fat-induced LDL hyper-responsiveness is directly linked to increased weight gain.
Fact-checked episodes
Publications